Drug intelligence / Profile preview

paracetamol + fexofenadine + phenylephrine

Development stage
Phase 3
Lead developer
Centaur Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Paracetamol + fexofenadine + phenylephrine is a fixed-dose combination medication used primarily for the symptomatic treatment of the common cold, allergic rhinitis, and related upper respiratory tract conditions. The combination contains three active ingredients with complementary mechanisms: - Paracetamol (acetaminophen) is an analgesic and antipyretic that works by inhibiting cyclooxygenase enzymes (COX-1, COX-2, COX-3) in the central nervous system to reduce pain and fever. - Fexofenadine is a second-generation antihistamine that selectively blocks histamine H1 receptor without significant sedative or anticholinergic effects, thereby relieving symptoms such as sneezing, runny nose, watery eyes, and itching. - Phenylephrine is a sympathomimetic decongestant that acts as an agonist at alpha1-adrenergic receptor in nasal mucosal arterioles to cause vasoconstriction and reduce nasal congestion. This combination provides effective relief from multiple symptoms associated with colds and allergies—including nasal congestion, rhinorrhea (runny nose), sneezing, sore throat, fever, headache, and body aches. Clinical studies have shown it to be both safe and effective for short-term use in adults[5][6][1].

Brand names
Sinarest FxpFexagon PlusFpp ActiveNamcold FXFepanil PlusDoxpist
Other names
fexofenadine + paracetamol + phenylephrinefexofenadine + phenylephrine + paracetamol
02

Targets

ADRA1A (α1A)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on paracetamol + fexofenadine + phenylephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + fexofenadine + phenylephrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call